GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

Source: 
Clinical Trials Arena
snippet: 

GSK and CureVac began testing a new influenza vaccine as the race to develop mRNA-based vaccines outside of Covid-19 continues to heat up.